Clinical trial

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-03-16

PhaseN/A

Study timeline

Study start (actual)2026-03-16Date precision: day

Registry last updated2026-08-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

TeplizumabDRUG · verified · RxNorm: teplizumab

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

MadridSpain2 ParisFrance2 LondonUnited Kingdom1 LeuvenBelgium1 HanoverGermany1 FrankfurtGermany1 BirminghamUnited Kingdom1 ZaragozaSpain1 BronFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07457580 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.